메뉴 건너뛰기




Volumn 9, Issue 10, 2011, Pages 1902-1915

Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: A meta-analysis

Author keywords

Low molecular weight heparin; Percutaneous coronary intervention; ST elevation myocardial infarction; Unfractionated heparin

Indexed keywords

CERTOPARIN; CLOPIDOGREL; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; TINZAPARIN;

EID: 80053424432     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04445.x     Document Type: Article
Times cited : (74)

References (43)
  • 1
    • 70450199115 scopus 로고    scopus 로고
    • Erratum in: J Am Coll Cardiol 2010;55:612. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • Kushner FG, Hand M, Smith SC Jr, King SB III, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE Jr, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009;54:2205-41. Erratum in: J Am Coll Cardiol 2010;55:612.
    • (2009) J Am Coll Cardiol , vol.54 , pp. 2205-2241
    • Kushner, F.G.1    Hand, M.2    Smith Jr, S.C.3    King III, S.B.4    Anderson, J.L.5    Antman, E.M.6    Bailey, S.R.7    Bates, E.R.8    Blankenship, J.C.9    Casey Jr, D.E.10    Green, L.A.11    Hochman, J.S.12    Jacobs, A.K.13    Krumholz, H.M.14    Morrison, D.A.15    Ornato, J.P.16    Pearle, D.L.17    Peterson, E.D.18    Sloan, M.A.19    Whitlow, P.L.20    more..
  • 3
    • 36148985732 scopus 로고    scopus 로고
    • Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials
    • De Luca G, Marino P. Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials. Am Heart J 2007; 154: 1085.e1-6.
    • (2007) Am Heart J , vol.154
    • De Luca, G.1    Marino, P.2
  • 4
    • 80053415124 scopus 로고    scopus 로고
    • The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Accessed 24 January
    • The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Accessed 24 January2011.
    • (2011)
  • 5
    • 0034685429 scopus 로고    scopus 로고
    • Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group
    • Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
    • (2000) JAMA , vol.283 , pp. 2008-2012
    • Stroup, D.F.1    Berlin, J.A.2    Morton, S.C.3    Olkin, I.4    Williamson, G.D.5    Rennie, D.6    Moher, D.7    Becker, B.J.8    Sipe, T.A.9    Thacker, S.B.10
  • 6
    • 79951477846 scopus 로고    scopus 로고
    • Practical and updated guidelines on performing meta-analyses of non-randomized studies in interventional cardiology
    • Navarese EP, Kozinski M, Pafundi T, Andreotti F, Buffon A, Servi SD, Kubica J. Practical and updated guidelines on performing meta-analyses of non-randomized studies in interventional cardiology. Cardiol J 2011; 18: 3-7.
    • (2011) Cardiol J , vol.18 , pp. 3-7
    • Navarese, E.P.1    Kozinski, M.2    Pafundi, T.3    Andreotti, F.4    Buffon, A.5    Servi, S.D.6    Kubica, J.7
  • 7
    • 0023025908 scopus 로고
    • Analysis of data from multiclinics trials
    • Fleiss JL. Analysis of data from multiclinics trials. Control Clin Trials 1986; 7: 267-75.
    • (1986) Control Clin Trials , vol.7 , pp. 267-275
    • Fleiss, J.L.1
  • 9
    • 0032477417 scopus 로고    scopus 로고
    • Bias in location and selection of studies
    • Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998; 31: 61-6.
    • (1998) BMJ , vol.31 , pp. 61-66
    • Egger, M.1    Smith, G.D.2
  • 10
    • 0033934949 scopus 로고    scopus 로고
    • Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
    • Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455-63.
    • (2000) Biometrics , vol.56 , pp. 455-463
    • Duval, S.1    Tweedie, R.2
  • 11
    • 0029785769 scopus 로고    scopus 로고
    • The relation between treatment benefit and underlying risk in meta-analysis
    • Sharp SJ, Thompson SG, Altman DG. The relation between treatment benefit and underlying risk in meta-analysis. BMJ 1996; 313: 735-8.
    • (1996) BMJ , vol.313 , pp. 735-738
    • Sharp, S.J.1    Thompson, S.G.2    Altman, D.G.3
  • 18
    • 56149103295 scopus 로고    scopus 로고
    • Primary percutaneous coronary intervention for ST-elevation myocardial infarction using an intravenous and subcutaneous enoxaparin low molecular weight heparin regimen
    • Khoobiar S, Mejevoi N, Kaid K, Boiangiu C, Setty S, Tanwir A, Khalid K, Cohen M. Primary percutaneous coronary intervention for ST-elevation myocardial infarction using an intravenous and subcutaneous enoxaparin low molecular weight heparin regimen. J Thromb Thrombolysis 2008; 26: 85-90.
    • (2008) J Thromb Thrombolysis , vol.26 , pp. 85-90
    • Khoobiar, S.1    Mejevoi, N.2    Kaid, K.3    Boiangiu, C.4    Setty, S.5    Tanwir, A.6    Khalid, K.7    Cohen, M.8
  • 20
    • 63049140130 scopus 로고    scopus 로고
    • Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention
    • Zeymer U, Gitt A, Zahn R, Jünger C, Bauer T, Heer T, Koeth O, Senges J. Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention. EuroIntervention 2009; 4: 524-8.
    • (2009) EuroIntervention , vol.4 , pp. 524-528
    • Zeymer, U.1    Gitt, A.2    Zahn, R.3    Jünger, C.4    Bauer, T.5    Heer, T.6    Koeth, O.7    Senges, J.8
  • 22
    • 14644424575 scopus 로고    scopus 로고
    • Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: an ENTIRE-TIMI 23 substudy
    • Ray KK, Morrow DA, Gibson CM, Murphy S, Antman EM, Braunwald E. Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: an ENTIRE-TIMI 23 substudy. Eur Heart J 2005; 26: 440-6.
    • (2005) Eur Heart J , vol.26 , pp. 440-446
    • Ray, K.K.1    Morrow, D.A.2    Gibson, C.M.3    Murphy, S.4    Antman, E.M.5    Braunwald, E.6
  • 24
    • 33748431522 scopus 로고    scopus 로고
    • Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention
    • Montalescot G, White HD, Gallo R. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med 2006; 355: 1006-17.
    • (2006) N Engl J Med , vol.355 , pp. 1006-1017
    • Montalescot, G.1    White, H.D.2    Gallo, R.3
  • 28
    • 8544279582 scopus 로고    scopus 로고
    • A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and safety of subcutaneous enoxaparin in non-Q-wave coronary events study group
    • Cohen M, Demers C, Gurfinkel EP, Turpie AG, Fromell GJ, Goodman S, Langer A, Califf RM, Fox KA, Premmereur J, Bigonzi F. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and safety of subcutaneous enoxaparin in non-Q-wave coronary events study group. N Engl J Med 1997; 337: 447-52.
    • (1997) N Engl J Med , vol.337 , pp. 447-452
    • Cohen, M.1    Demers, C.2    Gurfinkel, E.P.3    Turpie, A.G.4    Fromell, G.J.5    Goodman, S.6    Langer, A.7    Califf, R.M.8    Fox, K.A.9    Premmereur, J.10    Bigonzi, F.11
  • 30
    • 0036735080 scopus 로고    scopus 로고
    • Randomized double blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin
    • Cohen M, Theroux P, Borzak S, Frey MJ, White HD, van Mieghem W, Senatore F, Lis J, Mukherjee R, Harris K, Bigonzi F. Randomized double blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin. Am Heart J 2002; 144: 470-7.
    • (2002) Am Heart J , vol.144 , pp. 470-477
    • Cohen, M.1    Theroux, P.2    Borzak, S.3    Frey, M.J.4    White, H.D.5    van Mieghem, W.6    Senatore, F.7    Lis, J.8    Mukherjee, R.9    Harris, K.10    Bigonzi, F.11
  • 31
    • 0037458122 scopus 로고    scopus 로고
    • Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated Enoxaparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide
    • Goodman SG, Fitchett D, Armstrong PW, Tan M, Langer A. Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated Enoxaparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Circulation 2003; 107: 238-44.
    • (2003) Circulation , vol.107 , pp. 238-244
    • Goodman, S.G.1    Fitchett, D.2    Armstrong, P.W.3    Tan, M.4    Langer, A.5
  • 34
    • 0036554907 scopus 로고    scopus 로고
    • Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction
    • Baird SH, Menown IBA, McBride SJ, Trouton TG, Wilson C. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction. Eur Heart J 2002; 23: 627-32.
    • (2002) Eur Heart J , vol.23 , pp. 627-632
    • Baird, S.H.1    Menown, I.B.A.2    McBride, S.J.3    Trouton, T.G.4    Wilson, C.5
  • 35
    • 36148996461 scopus 로고    scopus 로고
    • Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction
    • Wang XK, Zhang Y, Yang CM, Wang Y, Liu GY. Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction. Clin Drug Investig 2006; 26: 341-9.
    • (2006) Clin Drug Investig , vol.26 , pp. 341-349
    • Wang, X.K.1    Zhang, Y.2    Yang, C.M.3    Wang, Y.4    Liu, G.Y.5
  • 36
    • 0035822605 scopus 로고    scopus 로고
    • Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractioned heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin. Second trial of Heparin and Aspirin Reperfusion Therapy (HART-II)
    • Ross AM, Molhoek P, Lundergan C, Knudtson M, Draoui Y, Regalado L, Le Louer V, Bigonzi F, Schwartz W, de Jong E, Coyne K. Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractioned heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin. Second trial of Heparin and Aspirin Reperfusion Therapy (HART-II). Circulation 2001; 104: 648-52.
    • (2001) Circulation , vol.104 , pp. 648-652
    • Ross, A.M.1    Molhoek, P.2    Lundergan, C.3    Knudtson, M.4    Draoui, Y.5    Regalado, L.6    Le Louer, V.7    Bigonzi, F.8    Schwartz, W.9    de Jong, E.10    Coyne, K.11
  • 37
    • 0038447936 scopus 로고    scopus 로고
    • Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting. The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction
    • Wallentin L, Goldstein P, Armstrong PW, Granger CB, Adgey AA, Arntz HR, Bogaerts K, Danays T, Lindahl B, Mäkijärvi M, Verheugt F, van de Werf F. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting. The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation 2003; 108: 135-42.
    • (2003) Circulation , vol.108 , pp. 135-142
    • Wallentin, L.1    Goldstein, P.2    Armstrong, P.W.3    Granger, C.B.4    Adgey, A.A.5    Arntz, H.R.6    Bogaerts, K.7    Danays, T.8    Lindahl, B.9    Mäkijärvi, M.10    Verheugt, F.11    van de Werf, F.12
  • 38
    • 0038814322 scopus 로고    scopus 로고
    • Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction - the ASSENT Plus study
    • Wallentin L, Bergstrand L, Dellborg M, Fellenius C, Granger CB, Lindahl B, Lins LE, Nilsson T, Pehrsson K, Siegbahn A, Swahn E. Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction - the ASSENT Plus study. Eur Heart J 2003; 24: 897-908.
    • (2003) Eur Heart J , vol.24 , pp. 897-908
    • Wallentin, L.1    Bergstrand, L.2    Dellborg, M.3    Fellenius, C.4    Granger, C.B.5    Lindahl, B.6    Lins, L.E.7    Nilsson, T.8    Pehrsson, K.9    Siegbahn, A.10    Swahn, E.11
  • 41
    • 80053397510 scopus 로고    scopus 로고
    • Use of low molecular weight heparin is associated with improved in-hospital survival of ST-elevation myocardial infarction patients who receive reperfusion therapy: results from the nationwide French FAST-MI registry
    • Danchin N, Collet J, Marco J, Charbonnier B, Cottin Y, Sans P, Puel J, Dentan G, Cambou JP. Use of low molecular weight heparin is associated with improved in-hospital survival of ST-elevation myocardial infarction patients who receive reperfusion therapy: results from the nationwide French FAST-MI registry. J Am Coll Cardiol 2007; 49: 184A-253A.
    • (2007) J Am Coll Cardiol , vol.49
    • Danchin, N.1    Collet, J.2    Marco, J.3    Charbonnier, B.4    Cottin, Y.5    Sans, P.6    Puel, J.7    Dentan, G.8    Cambou, J.P.9
  • 42
    • 38349106680 scopus 로고    scopus 로고
    • Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction
    • Zeymer U, Gitt A, Jünger C, Jünger C, Bauer T, Heer T, Koeth O, Senges J. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction. Thromb Haemost 2008; 99: 150-4.
    • (2008) Thromb Haemost , vol.99 , pp. 150-154
    • Zeymer, U.1    Gitt, A.2    Jünger, C.3    Jünger, C.4    Bauer, T.5    Heer, T.6    Koeth, O.7    Senges, J.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.